DennisLKolsonMD
Neurology • Philadelphia, PANeuroimmunology/Multiple Sclerosis
Professor, Neurology, Perelman School of Medicine
Dr. Kolson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
280C Clinical Research Building
University of Pennsylvania
Philadelphia, PA 19104Phone+1 215-573-3505
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1989 - 1992
Duke University HospitalResidency, Neurology, 1986 - 1989
UPMC Medical Education/MercyInternship, Internal Medicine, 1985 - 1986
University of Pittsburgh School of MedicineClass of 1985
Certifications & Licensure
PA State Medical License 1990 - 2024
NC State Medical License 1989 - 2005- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 373 citationsAlzheimer's A beta(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells.David G. Cook, Mark S. Forman, Jane C. Sung, Susan Leight, Dennis L. Kolson
Nature Medicine. 1997-09-01 - 61 citationsToxicity of TNFα and platelet activating factor for human NT2N neurons: A tissue culture model for human immunodeficiency virus dementiaSusan V Westmoreland, Dennis L. Kolson, Francisco Gonzalez-Scarano
Journal of Neurovirology. 1996-01-01 - 137 citationsTotal brain N-acetylaspartate: a new measure of disease load in MS.Oded Gonen, Isabelle Catalaa, James Babb, Yulin Ge, Lois J. Mannon
Neurology. 2000-01-11
Press Mentions
What It’s like to Live with Brain FogNovember 28th, 2022- Hope and Relief for Neurological Symptoms of Long COVID: The Penn Neuro COVID ClinicNovember 22nd, 2022
- More Than a Year Later, America Grapples with Long CovidAugust 15th, 2021
- Join now to see all
Grant Support
- Pathways Of HIV Neurodegeneration And Dimethyl Fumarate (Dmf/Mmf) NeuroprotectionNational Institute Of Mental Health2011–2012
- HIV Neural Apoptosis: Mechanisms, Pathways &ProtectionNational Institute Of Neurological Disorders And Stroke2007–2011
- Astrocyte Activation, Dysfunction &Apoptosis In HADNational Institute Of Neurological Disorders And Stroke2008–2009
- Astrocyte Activation, Dysfunction &Apoptosis In HADNational Institute Of Neurological Disorders And Stroke2005–2007
- HIV Neural Apoptosis:Mechanisms, Pathways &ProtectionNational Institute Of Neurological Disorders And Stroke2003–2006
- Aactg 5090: Selegiline For Treatment Of Hiv-Associated Cognitive ImpairmentNational Center For Research Resources2004–2005
- Reverse Pseudotype HIV 1 Targeting Of Neural CellsNational Institute Of Neurological Disorders And Stroke2000–2002
- ACTG 301--Memantine For AIDS Dementia Complex With Antiretroviral TherapyNational Center For Research Resources1998–2002
- Chemokines And Neuronal/Glial Function In AIDS DementiaNational Institute Of Neurological Disorders And Stroke1998–2001
- Neuronal Cell Functions In AIDS Dementia--A Unique ModelNational Institute Of Neurological Disorders And Stroke1996–2000
- ACTG 242--Amitriptyline And Mexiletine For Neuropathy In HIV PatientsNational Center For Research Resources1997–1999
- Human Immunodeficiency Virus Type 1 EffectsNational Institute Of Neurological Disorders And Stroke1994–1996
- Effects Of Human Immunodeficiency Virus Type 1 On Ne0National Institute Of Neurological Disorders And Stroke1992–1993
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
